AP NEWS

Bristol-Myers Squibb Announces Dividend

September 12, 2018

NEW YORK--(BUSINESS WIRE)--Sep 12, 2018--The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty cents ($0.40) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 1, 2018, to stockholders of record at the close of business on October 5, 2018.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable December 3, 2018 to stockholders of record at the close of business on November 6, 2018.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005819/en/

CONTACT: Bristol-Myers Squibb

Media:

Lisa McCormick Lavery, 609-252-7602

lisa.mccormicklavery@bms.com

or

Investors:

Tim Power, 609-252-7509

timothy.power@bms.com

or

Bill Szablewski, 609-252-5894

william.szablewski@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL GENERAL HEALTH

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2018.

PUB: 09/12/2018 04:10 PM/DISC: 09/12/2018 04:10 PM

http://www.businesswire.com/news/home/20180912005819/en

AP RADIO
Update hourly